Literature DB >> 34283646

Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer.

Rosario Mazzola1, Gianluisa Sicignano1, Francesco Cuccia1, Claudio Vitale1, Michele Rigo1, Niccolò Giaj-Levra1, Luca Nicosia1, Vanessa Figlia1, Francesco Ricchetti1, Giorgio Attinà1, Edoardo Pastorello1, Antonio De Simone1, Davide Gurrera1, Stefania Naccarato1, Ruggero Ruggieri1, Filippo Alongi1,2.   

Abstract

OBJECTIVES: MR-guided daily-adaptive radiotherapy is improving the accuracy in the planning and delivery phases of the treatment. Rectal hydrogel-spacer may help in mitigating organ motion, but few data are currently available.
METHODS: We aimed to assess any potential impact of the device on seminal vesicles motion by measuring translational and rotational shifts between the pre- and post-treatment MRI scans of a total of 50 fractions in the first 10 patients who underwent MR-guided prostate SBRT (35 Gy/5 fx). Of them, five patients received the hydrogel-spacer. The comparative analysis was performed using the Mann-Whitney U-test.
RESULTS: Median rotational shifts were: in anteroposterior 0° (range, 0.097°/0.112°; SD = 0.05°) vs 0° (-0.162/0.04°; SD = 0.07°) in the no-spacer subgroup (p = 0.36); lateral shifts were 0° (-0.1°/0.54°; SD = 0.28°) vs -0.85° in the no-spacer cohort (-1.56°/0.124°; SD = 0.054°; p = 0.22). Cranio-caudal shifts were 0° (-0.121°/0.029°; SD = 0.06°) in the spacer-cohort vs 0° (-0.066°/0.087°; SD = 0.69°; p = 0.53). Median translational shifts were: in anteroposterior 0.9 mm (-0.014 mm/0.031 mm; SD = 0.036 mm) in the spacer-group vs 0.030 mm (-0.14 mm/0.03 mm; SD = 0.032 mm; p = 0.8); latero-lateral shifts were -0.042 mm (-0.047 mm/0.07 mm; SD = 0.054 mm), vs -0.023 mm (-0.027 mm/-0.01 mm; SD = 0.023 mm) in the no-spacer group (p = 0.94). In cranio-caudal, statistically significant shifts were reported: 0.082 mm (0.06 mm/0.15 mm; SD = 0.04 mm) vs 0.06 mm (-0.06/0.08 mm; SD = 0.09 mm) in the no-spacer cohort (p = 0.031).
CONCLUSIONS: A favorable impact of the hydrogel-spacer on seminal vesicles motion was observed only in cranio-caudal translational shifts, although being not clinically significant. Further studies are required to fully investigate the potential contribution of this device on vesicles motion. ADVANCES IN KNOWLEDGE: MR-guided daily adaptive radiotherapy may represent a game changer for prostate stereotactic body radiotherapy, given the possibility to better visualize soft-tissues anatomy and to daily recalculate the treatment plan based on real-time conditions. The use of devices like rectal ballon or rectal gel spacers has gained interest in the last years for the possibility to better spare the rectum during prostate radiotherapy. This is one of the first experiences exploring the role of rectal spacer on seminal vesicles intrafraction motion during MR-guided SBRT for prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34283646      PMCID: PMC9328065          DOI: 10.1259/bjr.20210521

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.629


  18 in total

1.  Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer.

Authors:  Ruggero Ruggieri; Stefania Naccarato; Pavel Stavrev; Nadejda Stavreva; Sergio Fersino; Niccolò Giaj Levra; Rosario Mazzola; Pietro Mancosu; Marta Scorsetti; Filippo Alongi
Journal:  Br J Radiol       Date:  2015-08-03       Impact factor: 3.039

2.  Exploring the Margin Recipe for Online Adaptive Radiation Therapy for Intermediate-Risk Prostate Cancer: An Intrafractional Seminal Vesicles Motion Analysis.

Authors:  Yang Sheng; Taoran Li; W Robert Lee; Fang-Fang Yin; Q Jackie Wu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-02-24       Impact factor: 7.038

3.  Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy.

Authors:  Kirsten E I Deurloo; Roel J H M Steenbakkers; Lambert J Zijp; Josien A de Bois; Peter J C M Nowak; Coen R N Rasch; Marcel van Herk
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-01-01       Impact factor: 7.038

4.  Reply to Ghaffari et al. "In regard to Cuccia et al.: impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy."

Authors:  Francesco Cuccia; Filippo Alongi
Journal:  Radiat Oncol       Date:  2020-09-09       Impact factor: 3.481

5.  Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time.

Authors:  Ruggero Ruggieri; Michele Rigo; Stefania Naccarato; Davide Gurrera; Vanessa Figlia; Rosario Mazzola; Francesco Ricchetti; Luca Nicosia; Niccolò Giaj-Levra; Francesco Cuccia; Claudio Vitale; Nadejda Stavreva; Dobromir S Pressyanov; Pavel Stavrev; Roberto Pellegrini; Filippo Alongi
Journal:  Phys Med       Date:  2020-10-20       Impact factor: 2.685

6.  Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes.

Authors:  Rosario Mazzola; Vanessa Figlia; Michele Rigo; Francesco Cuccia; Francesco Ricchetti; Niccolò Giaj-Levra; Luca Nicosia; Claudio Vitale; Gianluisa Sicignano; Antonio De Simone; Stefania Naccarato; Ruggero Ruggieri; Filippo Alongi
Journal:  J Cancer Res Clin Oncol       Date:  2020-05-05       Impact factor: 4.553

Review 7.  MR-guidance in clinical reality: current treatment challenges and future perspectives.

Authors:  S Corradini; F Alongi; N Andratschke; C Belka; L Boldrini; F Cellini; J Debus; M Guckenberger; J Hörner-Rieber; F J Lagerwaard; R Mazzola; M A Palacios; M E P Philippens; C P J Raaijmakers; C H J Terhaard; V Valentini; M Niyazi
Journal:  Radiat Oncol       Date:  2019-06-03       Impact factor: 3.481

8.  Considering benefit and risk before routinely recommending SpaceOAR.

Authors:  William A Hall; Alison C Tree; David Dearnaley; Christopher C Parker; Vinay Prasad; Mack Roach; Colleen A F Lawton
Journal:  Lancet Oncol       Date:  2021-01       Impact factor: 41.316

9.  Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.

Authors:  Francesco Cuccia; Rosario Mazzola; Luca Nicosia; Vanessa Figlia; Niccolò Giaj-Levra; Francesco Ricchetti; Michele Rigo; Claudio Vitale; Beatrice Mantoan; Antonio De Simone; Gianluisa Sicignano; Ruggero Ruggieri; Stefano Cavalleri; Filippo Alongi
Journal:  Radiat Oncol       Date:  2020-07-22       Impact factor: 3.481

10.  1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment.

Authors:  Filippo Alongi; Michele Rigo; Vanessa Figlia; Francesco Cuccia; Niccolò Giaj-Levra; Luca Nicosia; Francesco Ricchetti; Gianluisa Sicignano; Antonio De Simone; Stefania Naccarato; Ruggero Ruggieri; Rosario Mazzola
Journal:  Radiat Oncol       Date:  2020-03-23       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.